Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Evocutis
Evocutis
Activities:
Regulatory
Research & Development
Skin Care
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Change of CEO at BASF
Lanxess announces change of leadership at Board of Management
Matthias Zachert joins as Chief Executive and Chairman from Merck KGaA
Tim Slomp joins executive board of Uhlmann
Slomp will succeed Peter Wagner as Managing Director Technology & Development in January 2018
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Upcoming event
CPhI South East Asia 2024
10-12 July 2024 | Exhibition and Conference | Bangkok, Thailand
See all
Related Content
Skin Care
Venn Life Sciences acquires trading assets of Evocutis
Including intellectual property rights to Labskin and anti-acne compound SYN1113
Regulatory
Evocutis and Bradford University Collaborate on pigmented LabSkin
Aim to discover improved ways of investigating common pigment-related skin conditions
Regulatory
Evocutis secures first contracts for LabSkin living skin equivalent
Offers an alternative to ethically sensitive and expensive animal and human volunteer testing
Research & Development
Evocutis joins European platform to promote alternatives to animal testing
After making presentation about its LabSkin technology
Ingredients
Syntopix develops microemulsions for healthcare and cosmetic products
Identifies two green surfactants for oral care
Manufacturing
Syntopix plans to buy Leeds Skin
Key attraction of acquisition is Leeds Skin’s LabSkin technology
Ingredients
Syntopix to develop new microemulsions
Wins support from Intelligent Formulation
Subscribe now